IgM Multiple Myeloma
Open Access
- 1 October 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 140 (4), 519-524
- https://doi.org/10.1309/ajcp0n7ielyunjgz
Abstract
To delineate the pathology of immunoglobulin M–producing multiple myeloma (IgM MM). Clinicopathologic data were reviewed for 15 cases meeting World Health Organization criteria for MM and having a serum IgM paraprotein. Immunohistochemistry was performed on diagnostic bone marrow specimens for common B-cell and plasma cell markers. Of the 15 IgM MM bone marrows reviewed, 6 (40%) had lymphoplasmacytoid cytology, and 12 (80%) expressed CD19, CD20, and/or CD45. Cyclin D1 expression was common (11 cases, 73%) and usually associated with t(11;14). No cases expressed CD5 or had an associated CD5-positive B-cell population. CD117 was positive in 20% of cases. The frequent B-cell–associated antigen expression by IgM MM distinguishes it from other MM types, causing significant pathologic overlap with lymphoplasmacytic lymphoma (LPL). However, IgM MM is usually distinguished from LPL by aberrant cyclin D1 expression or t(11;14). Therefore, assessing for these abnormalities is recommended when evaluating bone marrow involvement by IgM-associated lymphoplasmacytoid disorders.Keywords
This publication has 19 references indexed in Scilit:
- MYD88 L265P mutation in Waldenstrom macroglobulinemiaBlood, 2013
- IgM multiple myeloma: More on a rare and heterogeneous diseaseAmerican Journal of Hematology, 2011
- Defining IgM multiple myelomaAmerican Journal of Hematology, 2011
- Molecular Characteristics of Mantle Cell Lymphoma Presenting With Clonal Plasma Cell ComponentThe American Journal of Surgical Pathology, 2011
- Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR StudyClinical Lymphoma Myeloma and Leukemia, 2010
- Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) GuidelinesMayo Clinic Proceedings, 2010
- IgM myeloma: a rare entity characterized by a CD20−CD56−CD117− immunophenotype and the t(11;14)British Journal of Haematology, 2008
- Genetic Abnormalities and Patterns of Antigenic Expression in Multiple MyelomaClinical Cancer Research, 2005
- Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variantsBlood, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003